Kenneth J. Hillan - Aug 20, 2022 Form 4 Insider Report for 23andMe Holding Co. (ME)

Role
Chief Therapeutics Officer
Signature
/s/ Kenneth Hillan, by Kathy Hibbs, attorney-in-fact
Stock symbol
ME
Transactions as of
Aug 20, 2022
Transactions value $
-$15,411
Form type
4
Date filed
8/22/2022, 06:12 PM
Previous filing
Jun 2, 2022
Next filing
Aug 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ME Class A Common Stock Tax liability -$15.4K -4.63K -2.21% $3.33 205K Aug 20, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The closing price on August 19, 2022, the fair market used for the transaction date.